Skip to main content
SpringerLink
Log in

Comparison of Angio-CT and cone-beam CT-guided immediate radiofrequency ablation after transcatheter arterial chemoembolization for large hepatocellular carcinoma

  • Interventional Radiology
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the rapeutic effectiveness of Angio-CT or cone-beam CT (CBCT)-guided immediate radiofrequency ablation (RFA) after transcatheter arterial chemoembolization (TACE) for large hepatocellular carcinoma (HCC).

Methods

117 large HCC patients (mean maximum diameter: 9.3 cm; range 5.3–17.7 cm) were retrospective studied and divided into Angio-CT group (n = 66 cases), CBCT group (n = 21 cases), and single TACE group (n = 30 cases) according to treatment (Angio-CT/CBCT-guided immediate RFA after TACE, single TACE, respectively). The operative time, effective radiation dose, local–regional tumor responses, overall survival (OS), and progression‑free survival (PFS) time and complications were recorded.

Results

The operative time and effective radiation dose of Angio-CT group and CBCT group were higher than those of TACE group (P < 0.01). The local–regional tumor responses on 1-month follow-up MRI (complete response + partial response) of Angio-CT group and CBCT group were 100%, which were significantly higher than that of single TACE group (76.7%, P < 0.05). There was no significant difference in local–regional tumor responses of 1-month follow-up between Angio-CT group and CBCT group (P = 0.831). The median PFS and OS time of Angio-CT group were 14.7 ± 1.43 months and 18.21 ± 0.88 months, CBCT group were 13.9 ± 1.53 months and 17.87 ± 1.78 months, TACE group were 10.4 ± 1.21 months and 12.87 ± 0.91 months, respectively. No procedure-related major complications occurred.

Conclusions

MIYABI Angio-CT or CBCT-guided immediate RFA after TACE for large HCC both have more effective than single TACE. The former is worth popularizing, due to its advantages of convenience, shorter operative time, and less radiation dose for doctors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Huang G, Lin M, Xie X, Liu B, Xu Z, Lencioni R, Lu M, Kuang M. Combined radiofrequency ablation and ethanol injection with a multipronged needle for the treatment of medium and large hepatocellular carcinoma. Eur Radiol. 2014;24(7):1565-71

  2. Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C, Rossi S. Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice? Hepatology. 2008;47(1):82-9

  3. Abdelaziz AO, Nabeel MM, Elbaz TM, Shousha HI, Hassan EM, Mahmoud SH, Rashed NA, Ibrahim MM, Abdelmaksoud AH. Microwave ablation versus transarterial chemoembolization in large hepatocellular carcinoma: prospective analysis. Scand J Gastroenterol. 2015;50(4):479-84

  4. Wang ZJ, Wang MQ, Duan F, Song P, Liu FY, Wang Y, Yan JY, Li K, Yuan K. Clinical application of transcatheter arterial chemoembolization combined with synchronous C-arm cone-beam CT guided radiofrequency ablation in treatment of large hepatocellular carcinoma. Asian Pac J Cancer Prev. 2013;14(3):1649-54

  5. Gao F, Gu YK, Fan WJ, Zhang L, Huang JH. Evaluation of transarterial chemoembolization combined with percutaneous ethanol ablation for large hepatocellular carcinoma. World J Gastroenterol. 2011;17(26):3145-50

  6. Tu JF, Xu HH, Ying XH, Wang YH, Zhang DK, Tu CY, Ji JS. Comparative study of several microinvasive treatments for large hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2015;19(1):45-53

  7. Mulier S, Ni Y, Jamart J, Ruers T, Marchal G, Michel L. Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg. 2005;242(2):158-71

  8. Fan WZ, Yang JY, Lu MD, Xie XY, Yin XY, Huang YH, Kuang M, Li HP, Xu HX, Li JP. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]. Zhonghua Yi Xue Za Zhi. 2011;91(31):2190-4

  9. Veltri A, Moretto P, Doriguzzi A, Pagano E, Carrara G, Gandini G. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol. 2006;16(3):661-9

  10. Yamakado K, Nakatsuka A, Ohmori S, Shiraki K, Nakano T, Ikoma J, Adachi Y, Takeda K. Radiofrequency ablation combined with chemoembolization in hepatocellular carcinoma: treatment response based on tumor size and morphology. J Vasc Interv Radiol. 2002;13(12):1225-32

  11. Wang W, Shi J, Xie WF. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis. Liver Int. 2010;30(5):741-9

  12. Yin XY, Xie XY, Lu MD, Xu HX, Xu ZF, Kuang M, Liu GJ, Liang JY, Lau WY. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors. Cancer. 2009;115(9):1914-23

  13. Kudo M. Radiofrequency ablation for hepatocellular carcinoma: updated review in 2010. Oncology. 2010;78 Suppl 1:113-24

  14. DeMarco JJ, Cagnon CH, Cody DD, Stevens DM, McCollough CH, O’Daniel J, McNitt-Gray MF. A Monte Carlo based method to estimate radiation dose from multidetector CT (MDCT): cylindrical and anthropomorphic phantoms. Phys Med Biol. 2005;50(17):3989-4004

  15. Yan JY, Zhang JL, Wang MQ, Yuan K, Bai YH, Wang Y, Xin HN, Wang ZJ, Liu FY, Duan F, et al. Combined transcatheter arterial chemoembolization and radiofrequency ablation in single-session for solitary hepatocellular carcinoma larger than 7 cm. Asia Pac J Clin Oncol. 2017

  16. Zuo TY, Liu FY, Wang MQ, Chen XX. Transcatheter Arterial Chemoembolization Combined with Simultaneous Computed Tomography-guided Radiofrequency Ablation for Large Hepatocellular Carcinomas. Chin Med J (Engl). 2017;130(22):2666-73

  17. Wang ZJ, Wang MQ, Duan F, Song P, Liu FY, Chang ZF, Wang Y, Yan JY, Li K. Transcatheter arterial chemoembolization followed by immediate radiofrequency ablation for large solitary hepatocellular carcinomas. World J Gastroenterol. 2013;19(26):4192-9

  18. Bhardwaj N, Strickland AD, Ahmad F, Dennison AR, Lloyd DM (2010) Liver ablation techniques: a review. Surg Endosc. 24(2):254–265

    Article  CAS  Google Scholar 

  19. Ke S, Ding X, Gao J, Gao K, Qian X, Cao B, Li M, Sun W. Solitary huge hepatocellular carcinomas 10 cm or larger may be completely ablated by repeated radiofrequency ablation combined with chemoembolization: Initial experience with 9 patients. Mol Med Rep. 2012;5(3):832-6

  20. Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis. 2010;30(1):52-60

  21. Ye SL, Chen X, Yang J, Bie P, Zhang S, Liu F, Liu L, Zhou J, Dou K, Hao C, et al. Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study. Oncotarget. 2016;7(6):6639-48

  22. Ng SH, Lin CY, Chan SC, Yen TC, Liao CT, Chang JT, Ko SF, Wang HM, Huang SF, Lin YC, et al. Dynamic contrast-enhanced MR imaging predicts local control in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiotherapy. PLoS One. 2013;8(8):e72230

  23. Morant JJ, Salvado M, Hernandez-Giron I, Casanovas R, Ortega R, Calzado A. Dosimetry of a cone beam CT device for oral and maxillofacial radiology using Monte Carlo techniques and ICRP adult reference computational phantoms. Dentomaxillofac Radiol. 2013;42(3):92555893

  24. Fang ZX, Cheng D, Fang ZH, Song L, Lang qi HE. Transcatheter arterial chemoembolization combined with radiofrequency ablation in treatment of large hepatocellular carcinoma. Modern Digestion & Intervention. 2012

  25. Kashiwagi N, Nakanishi K, Kozuka T, Sato Y, Tanaka K, Tsukaguchi I, Uemura H, Fujii T, Yoshino K, Tomiyama N. Vascular supply with angio-CT for superselective intra-arterial chemotherapy in advanced maxillary sinus cancer. Br J Radiol. 2010;83(986):171-8

  26. Lee IJ, Chung JW, Yin YH, Kim HC, Kim YI, Jae HJ, Park JH. Cone-Beam Computed Tomography (CBCT) Hepatic Arteriography in Chemoembolization for Hepatocellular Carcinoma: Performance Depicting Tumors and Tumor Feeders. Cardiovasc Intervent Radiol. 2015;38(5):1218-30

  27. Kumano S, Tanaka H, Sugawara Y, Tsuda T, Hirata M, Mochizuki T, editors. Advantages of a Combined Angiography and CT (Angio-CT) System Using 16-channel MDCT for Better Treatment of Hepatocellular Carcinomas (HCCs). Radiological Society of North America 2005 Scientific Assembly and Meeting; 2005

  28. Tanaka T, Inoue M, Nishiofuku H, Anai H, Sakaguchi H, Kichikawa K, editors. Current Role of Hybrid Interventional CT/Angio System Compared with C-Arm CT. Radiological Society of North America 2012 Scientific Assembly and Meeting; 2014

  29. Sone M, Arai Y, Takeuchi Y, Sugawara S, Tomimatsu H, Morita S, Okamoto D, editors. Angio-CT System: Reasons Why It is Useful in Non-vascular Interventions. Radiological Society of North America 2013 Scientific Assembly and Meeting; 2013

  30. Ben-Shlomo A, Cohen D, Bruckheimer E, Bachar GN, Konstantinovsky R, Birk E, Atar E. Comparing Effective Doses During Image-Guided Core Needle Biopsies with Computed Tomography Versus C-Arm Cone Beam CT Using Adult and Pediatric Phantoms. Cardiovasc Intervent Radiol. 2016;39(5):732-9

  31. Morimoto M, Numata K, Kondo M, Nozaki A, Hamaguchi S, Takebayashi S, Tanaka K. C-arm cone beam CT for hepatic tumor ablation under real-time 3D imaging. AJR Am J Roentgenol. 2010;194(5):W452-4

  32. Tanaka T, Arai Y, Inaba Y, Inoue M, Nishiofuku H, Anai H, Hori S, Sakaguchi H, Kichikawa K. Current role of hybrid CT/angiography system compared with C-arm cone beam CT for interventional oncology. Br J Radiol. 2014;87(1041):20140126

Download references

Funding

This study was funded by grants from The National Natural Science Foundation of China (No. 81671800), and The Natural Science Foundation of Beijing Municipality (No. 7172204)

Author information

Authors and Affiliations

  1. Department of Interventional Radiology, The First Medical Center of PLA General Hospital, No. 28 Fuxing Road, Beijing, 100853, China

    Hongjun Yuan, Xin Li, Xiaomei Tian, Kan Ji & Fengyong Liu

Authors
  1. Hongjun Yuan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xin Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaomei Tian
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kan Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fengyong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fengyong Liu.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Ethical approval

For retrospective studies, this type of study formal consent is not required.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, H., Li, X., Tian, X. et al. Comparison of Angio-CT and cone-beam CT-guided immediate radiofrequency ablation after transcatheter arterial chemoembolization for large hepatocellular carcinoma. Abdom Radiol 45, 2585–2592 (2020). https://doi.org/10.1007/s00261-020-02462-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-020-02462-1

Keywords

Search

Navigation